Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-22 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
S | Common Stock | D | 833 | $22.87 - $22.87 | $19,050 |
| 2024-04-12 | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P
(Director) |
S | Common Stock | D | 80000 | $24.05 - $25.16 | $1,945,784 |
| 2024-04-12 | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P
(Director) |
M | Common Stock | A | 99624 | $4.34 - $4.34 | $432,567 |
| 2024-04-08 | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew
(See Remarks) |
S | Common Stock | D | 12532 | $24.64 - $24.64 | $308,763 |
| 2024-04-01 | ROCKET PHARMACEUTICALS, INC. | Ondrey Aaron
(Chief Financial Officer) |
A | Common Stock | A | 46781 | $0.00 - $0.00 | $0 |
| 2024-03-21 | ROCKET PHARMACEUTICALS, INC. | Makker Gotham
(Director) |
S | Common Stock | D | 274000 | $28.43 - $28.43 | $7,790,943 |
| 2024-03-21 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
S | Common Stock | D | 2490 | $28.10 - $28.10 | $69,978 |
| 2022-02-14 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
J | Common Stock | A | 36212 | $0.00 - $0.00 | $0 |
| 2024-02-29 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
S | Common Stock | D | 10000 | $29.84 - $29.84 | $298,450 |
| 2024-02-29 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
M | Common Stock | A | 10000 | $12.55 - $12.55 | $125,500 |
| 2024-02-29 | ROCKET PHARMACEUTICALS, INC. | Wilson Martin
(General Counsel) |
S | Common Stock | D | 4100 | $29.33 - $29.33 | $120,257 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Wilson Martin
(General Counsel) |
S | Common Stock | D | 3576 | $29.84 - $29.84 | $106,700 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Wilson Martin
(General Counsel) |
A | Common Stock | A | 16644 | $0.00 - $0.00 | $0 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari
(See Remarks) |
S | Common Stock | D | 7132 | $29.84 - $29.84 | $212,804 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari
(See Remarks) |
A | Common Stock | A | 33288 | $0.00 - $0.00 | $0 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
S | Common Stock | D | 3238 | $29.84 - $29.84 | $96,615 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
A | Common Stock | A | 8322 | $0.00 - $0.00 | $0 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew
(Chief Medical Officer) |
A | Common Stock | A | 11096 | $0.00 - $0.00 | $0 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav
(CEO) |
S | Common Stock | D | 20272 | $29.84 - $29.84 | $604,875 |
| 2024-02-16 | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav
(CEO) |
A | Common Stock | A | 66577 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav
(CEO) |
M | Common Stock | D | 46828 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari
(See Remarks) |
M | Common Stock | A | 26189 | $0.00 - $0.00 | $0 |
| 2024-01-22 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
S | Common Stock | D | 638 | $27.20 - $27.20 | $17,355 |
| 2024-01-18 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
M | Common Stock | A | 1586 | $0.00 - $0.00 | $0 |
| 2023-11-15 | ROCKET PHARMACEUTICALS, INC. | Makker Gotham
(Director) |
S | Common Stock | D | 20000 | $22.53 - $22.53 | $450,646 |
| 2023-11-14 | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari
(See Remarks) |
M | Common Stock | A | 3989 | $0.00 - $0.00 | $0 |
| 2023-11-14 | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav
(CEO) |
M | Common Stock | D | 7979 | $0.00 - $0.00 | $0 |
| 2023-11-14 | ROCKET PHARMACEUTICALS, INC. | Militello John
(See Remarks) |
M | Common Stock | A | 725 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |